Diaceutics PLC Purchase of Shares and PDMR Shareholding
January 31 2025 - 3:13AM
RNS Regulatory News
RNS Number : 4627V
Diaceutics PLC
31 January 2025
Diaceutics
PLC
Purchase of Shares and PDMR
Shareholding
New York, Belfast and London, 31
January 2025 - Diaceutics PLC (AIM: DXRX), a leading
technology and solutions provider to the pharma and biotech
industry, announces that on 30 January
2025, Graham Paterson, the Senior Independent Non-Executive
Director of Diaceutics PLC, purchased 11,643 ordinary shares of
£0.002 in the capital of the Company ("Ordinary Shares") at a price
of 137.5 pence per Ordinary Share. As a result of the purchase,
Graham's shareholding is 85,141 Ordinary Shares, representing
approximately 0.10% of the Company's issued share
capital.
Enquiries:
|
Diaceutics
PLC
|
|
|
Ryan Keeling, Chief Executive
Officer
|
Tel: +44 (0)28 9040
6500
|
|
Nick Roberts, Chief Financial
Officer
|
investorrelations@diaceutics.com
|
|
|
|
|
Canaccord
Genuity Limited (Nomad & Broker)
|
Tel: +44 (0)20 7253
8000
|
|
Simon Bridges, Andrew Potts, Harry
Rees
|
|
|
|
|
About Diaceutics
At Diaceutics we believe that every
patient should get the opportunity to receive the right test and
the right therapy to positively impact their disease outcome. We
provide the world's leading pharma and biotech companies with an
end-to-end commercialisation solution for precision medicines
through data analytics, scientific and advisory services enabled by
our platform DXRX - The Diagnostics Network ®.
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Graham Paterson
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Non-Executive Director
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN:
GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Purchase
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
137.5 p
|
11,643
|
|
|
|
|
e.
|
Date of the transaction
|
30 January 2025
|
|
f.
|
Place of the transaction
|
AIM Market of the London Stock
Exchange
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHFIFLALLILVIE
Diaceutics (LSE:DXRX)
Historical Stock Chart
From Jan 2025 to Feb 2025
Diaceutics (LSE:DXRX)
Historical Stock Chart
From Feb 2024 to Feb 2025
